What is VIVEVE?
Viveve is a safe and effective treatment option for women looking to improve post-childbirth vaginal laxity, decrease urinary incontinence, or heighten sensation during sex. 1 in 3 women have reported issues with vaginal laxity and urinary incontinence and is very common issue for women due to childbirth or aging. This treatment employs cryogen-cooled monopolar radiofrequency (CMRF) to produce healthy collagen and revived sensation of intimate wellness. This innovative treatment can give women long awaited for long-lasting results.
The Viveve treatment targets:
Vaginal laxity (looseness or overstretched vaginal wall)
Vaginal lubrication and reducing painful intercourse
Stress or urge incontinence
The quality and intensity of climax
With only a single 60-minute treatment session, this treatment can stimulate the body’s natural collagen formation process. After just one treatment, patients notice significant improvements in vaginal laxity, sexual health and stress urinary incontinence.
Viveve is different from other treatments offered, such as the Mona Lisa, and is the only treatment that offers cryogen-cooled monopolar radiofrequency.
Who is a good candidate for Viveve?
Post-Childbirth Vaginal Laxity
New mothers often experience vaginal laxity, resulting from the expansion of the vaginal canal during childbirth. Vaginal looseness and overstretched tissue can lead to reduced sexual sensitivity and urinary incontinence. Those who suffer from these problems can now feel relief after 6-12 weeks after Viveve. This treatment is effective whether it's your first time giving birth of the fifth.
Women who experience a lack of vaginal rigidity and sensitivity will often experience adverse effects on their sexual stimulation over time. This loose tissue and its resulting negative symptoms can be caused by medical conditions, childbirth, age, or a hormone imbalance. The Viveve utilizes radio frequency technology to repair existing tissue. This helps restore the elastin and collagen necessary for a healthy, tight and sensitive vagina. Women who have experienced a loss of sensitivity or inadequate climax sensations due to vaginl laxity can now see long term results. These results, generated by the Viveve treatment, can help aid in the quality and intensity of your climaxes, and create a more sensational experience for you and your partner.
Vaginal Laxity and Urinary Incontinence
Stress incontinence and urge incontinence are problems that affect more women than may be expected. Although both issues have to deal with loss of control of urination, it is important to note the differences. Stress incontinence is the inability to prevent leakage when coughing, sneezing, or exercising. While urge incontinence is the sudden and strong need to urinate but struggling to make it to the toilet on time. Luckily, Viveve can help resolve both of these issues.
Usually incontinence becomes a problem during menopause, postmenopause or postpartum. Vaginal laxity is the leading cause of these forms of incontinence, especially menopausal and postmenopausal women. This laxity is often due to a decrease in collagen production and the deterioration of estrogen levels. With just a single treatment, Viveve can help remedy these issues by stimulating collagen growth through a non-invasive, low-risk application of heat to the vaginal wall. As the tissue is restored, the vaginal wall will become more supple, and the tightness will improve your body’s ability to properly manage urine flow.
Viveve uses innovative technology that is comfortable and clinically proven with a 96% “worth it” rating in patient satisfaction.
Q: What is Radio Frequency technology?
A: Radio Frequency (RF) is used by the Viveve system to heat the collagen helix in the applied area, causing protein to reform and rebuild. RF technology has been utilized in medical applications for over 75 years, and has been successfully used for non-ablative skin rejuvenations, treatment of unwanted hair, and other treatments.
Q: How do I know it will work?
A: Clinical studies have been published in the Journal of Sexual Medicine and the Journal of Women’s Health. Results analyzed from studies done with a total of 54 in the U.S. and Japan Studies showed statistically significant improvement in vaginal tightness, to pre-childbirth levels, at 1, 3, 6, and 12 months following treatment. At 12 months, improved and sustained tightness was shown by 88% of the women. Significant improvement in sexual satisfaction was indicated through 12 month follow-up. These results were achieved after a single, painless, office-based Viveve Procedure.
Q: How safe is it?
A: Based on available clinical data, the Viveve Treatment is safe and effective. Government regulatory agencies, in countries where the Viveve System is available for sale, have reviewed the safety profile in detail, prior to granting a medical device license or approval to sell or distribute the product.
Q: Are there any side effects associated with the Viveve?
A: No, most patients do not experience any side effects during or following the procedure.
Q: Will I be able to return to work immediately following the procedure?
A: Yes, in most cases you will be able to return to your normal daily activities after receiving the Viveve treatment.
Q: How long does it take?
A: Viveve takes about 60 minutes and is done in-office.
Q: Will it be painful?
A: Most patients experience a heating and cooling sensation during treatment but there is usually no discomfort or pain.